Correlation Between Dupont De and Processa Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Dupont De and Processa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dupont De and Processa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dupont De Nemours and Processa Pharmaceuticals, you can compare the effects of market volatilities on Dupont De and Processa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dupont De with a short position of Processa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dupont De and Processa Pharmaceuticals.
Diversification Opportunities for Dupont De and Processa Pharmaceuticals
0.13 | Correlation Coefficient |
Average diversification
The 3 months correlation between Dupont and Processa is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Dupont De Nemours and Processa Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Processa Pharmaceuticals and Dupont De is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dupont De Nemours are associated (or correlated) with Processa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Processa Pharmaceuticals has no effect on the direction of Dupont De i.e., Dupont De and Processa Pharmaceuticals go up and down completely randomly.
Pair Corralation between Dupont De and Processa Pharmaceuticals
Allowing for the 90-day total investment horizon Dupont De Nemours is expected to generate 0.13 times more return on investment than Processa Pharmaceuticals. However, Dupont De Nemours is 7.84 times less risky than Processa Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. Processa Pharmaceuticals is currently generating about -0.01 per unit of risk. If you would invest 6,874 in Dupont De Nemours on August 31, 2024 and sell it today you would earn a total of 1,485 from holding Dupont De Nemours or generate 21.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dupont De Nemours vs. Processa Pharmaceuticals
Performance |
| Timeline |
| Dupont De Nemours |
| Processa Pharmaceuticals |
Dupont De and Processa Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dupont De and Processa Pharmaceuticals
The main advantage of trading using opposite Dupont De and Processa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dupont De position performs unexpectedly, Processa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Processa Pharmaceuticals will offset losses from the drop in Processa Pharmaceuticals' long position.| Dupont De vs. Eastman Chemical | Dupont De vs. Linde plc Ordinary | Dupont De vs. Ecolab Inc | Dupont De vs. Sherwin Williams Co |
| Processa Pharmaceuticals vs. Alpha Cognition | Processa Pharmaceuticals vs. Acurx Pharmaceuticals LLC | Processa Pharmaceuticals vs. Fennec Pharmaceuticals | Processa Pharmaceuticals vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |